Antimicrobial Susceptibility of Francisella tularensis Isolates in the United States, 2009-2018

Jamie Choat; John Young; Jeannine M Petersen; Elizabeth A Dietrich

doi:10.1093/cid/ciad680

Antimicrobial Susceptibility of Francisella tularensis Isolates in the United States, 2009-2018

Clin Infect Dis. 2024 Jan 31;78(Suppl 1):S4-S6. doi: 10.1093/cid/ciad680.

Authors

Jamie Choat¹, John Young¹, Jeannine M Petersen¹, Elizabeth A Dietrich¹

Affiliation

¹ Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

PMID: 38294116
DOI: 10.1093/cid/ciad680

Abstract

Francisella tularensis is the causative agent of tularemia. We tested the susceptibility of 278 F. tularensis isolates from the United States received during 2009-2018 to 8 antimicrobial drugs (ciprofloxacin, levofloxacin, doxycycline, tetracycline, gentamicin, streptomycin, chloramphenicol, and erythromycin). All isolates were susceptible to all tested drugs.

Keywords: Francisella tularensis; antimicrobial susceptibility; minimum inhibitory concentration.

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2024.

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Doxycycline / pharmacology
Doxycycline / therapeutic use
Francisella tularensis*
Humans
Microbial Sensitivity Tests
Tularemia* / drug therapy
Tularemia* / epidemiology
United States / epidemiology

Substances

Anti-Bacterial Agents
Doxycycline

Grants and funding

CC/CDC HHS/United States